Vigonvita Life Sciences
Clinical trials sponsored by Vigonvita Life Sciences, explained in plain language.
-
Meal timing matters: new drug VV913 tested with food in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study looks at how eating a high-fat or standard meal changes the way the body absorbs a single dose of VV913. It involves 12 healthy Chinese men aged 18 to 45. The goal is to gather safety and drug-level information, not to treat any disease.
Phase: PHASE1 • Sponsor: Vigonvita Life Sciences • Aim: Knowledge-focused
Last updated May 17, 2026 08:03 UTC
-
Healthy volunteers to test new drug VV913 in early safety study
Knowledge-focused Not yet recruitingThis study is an early-stage trial to check the safety of a new drug called VV913 in healthy Chinese men aged 18 to 45. It involves giving multiple doses of the drug or a placebo to see how the body handles it and if any side effects occur. The goal is to gather safety and drug-l…
Phase: EARLY_PHASE1 • Sponsor: Vigonvita Life Sciences • Aim: Knowledge-focused
Last updated May 17, 2026 08:01 UTC